Cholesterol reduction by methyl-β-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells
- 15 February 2007
- journal article
- Published by Elsevier BV in Biochemical Pharmacology
- Vol. 73 (4), 534-549
- https://doi.org/10.1016/j.bcp.2006.10.032
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Rafts defined: a report on the Keystone symposium on lipid rafts and cell functionJournal of Lipid Research, 2006
- Adenylyl Cyclase Superactivation Induced by Long-Term Treatment with Opioid Agonist Is Dependent on Receptor Localized within Lipid Rafts and Is Independent of Receptor InternalizationMolecular Pharmacology, 2006
- Lipid Rafts Control Signaling of Type-1 Cannabinoid Receptors in Neuronal CellsJournal of Biological Chemistry, 2005
- Agonist-specific regulation of the δ-opioid receptorLife Sciences, 2004
- Cholesterol-Dependent Association of Caveolin-1 with the Transducin α Subunit in Bovine Photoreceptor Rod Outer Segments: Disruption by Cyclodextrin and Guanosine 5‘-O-(3-Thiotriphosphate)Biochemistry, 2003
- Heterologous Desensitization Mediated by G Protein-specific Binding to CaveolinPublished by Elsevier BV ,2000
- δ and κ Opioid Receptors Are Differentially Regulated by Dynamin-dependent Endocytosis When Activated by the Same Alkaloid AgonistPublished by Elsevier BV ,1997
- Caveolin, a protein component of caveolae membrane coatsCell, 1992
- Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surfaceCell, 1992
- Anatomy of CNS opioid receptorsTrends in Neurosciences, 1988